A New Binding Assay of von Willebrand Factor and Glycoprotein Ib Using Solid-Phase Biotinylated Platelets
To obtain compounds that inhibit the interaction of von Willebrand factor (vWF) and glycoprotein (GP) Ib, a novel binding assay was established. The binding of fixed platelets to vWF-R497 mutant was quantified by a solid phase assay. In this assay, fixed platelets bound to the vWF-R497 mutant, carry...
Saved in:
Main Authors: | Kenji Hayata (Author), Takayuki Nakayama (Author), Tadashi Matsushita (Author), Katsuichi Sakano (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2008-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Establishment of New Highly Insulin-Sensitive Cell Lines and Screening of Compounds to Facilitate Glucose Consumption
by: Kenji Hayata, et al.
Published: (2008) -
Pseudo (Platelet-type) von Willebrand disease in pregnancy: a case report
by: Grover Neetu, et al.
Published: (2013) -
Platelet aggregation and von Willebrand factor in patients with artherial hypertension combined with osteoarthritis
by: Viktoriya Rodionova, et al.
Published: (2017) -
VON WILLEBRAND DISEASE
by: Valeriu Popescu, et al.
Published: (2009) -
Recombinant von Willebrand Factor for Pediatric Patient with von Willebrand Disease: First Report in Korea
by: Seoin Kim, et al.
Published: (2021)